MEN1 and gastric neuroendocrine tumor G1: This estimate was calculated from the differences in the NIH prospective study of 57 consecutive MEN1/ZES patients in which gastric carcinoid tumors were found in 23% of the patients [344], whereas in a similar study involving 106 patients with sporadic ZES [345], 0% had gastric carcinoids.